These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 24440403)

  • 21. Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.
    Vo AQ; Feng X; Zhang J; Zhang F; Repka MA
    Int J Pharm; 2018 Oct; 550(1-2):216-228. PubMed ID: 30142354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy.
    Ousset A; Chavez PF; Meeus J; Robin F; Schubert MA; Somville P; Dodou K
    Pharmaceutics; 2018 Mar; 10(1):. PubMed ID: 29518936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of polymeric excipients on the physical properties and performance of amorphous dispersions: Part I, free volume and glass transition.
    Li J; Zhao J; Tao L; Wang J; Waknis V; Pan D; Hubert M; Raghavan K; Patel J
    Pharm Res; 2015 Feb; 32(2):500-15. PubMed ID: 25107427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurements.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Mol Pharm; 2013 Oct; 10(10):3801-11. PubMed ID: 24025080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equilibrium state at supersaturated drug concentration achieved by hydroxypropyl methylcellulose acetate succinate: molecular characterization using (1)H NMR technique.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Mol Pharm; 2015 Apr; 12(4):1096-104. PubMed ID: 25723893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements.
    Ueda K; Higashi K; Limwikrant W; Sekine S; Horie T; Yamamoto K; Moribe K
    Mol Pharm; 2012 Nov; 9(11):3023-33. PubMed ID: 22970935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiscale Computational Modeling of the Nanostructure of Solid Dispersions of Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) and Phenytoin.
    Huang W; Mandal T; Larson RG
    Mol Pharm; 2017 Oct; 14(10):3422-3435. PubMed ID: 28829134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions.
    Tanno F; Nishiyama Y; Kokubo H; Obara S
    Drug Dev Ind Pharm; 2004 Jan; 30(1):9-17. PubMed ID: 15000425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging Applications of Hydroxypropyl Methylcellulose Acetate Succinate: Different Aspects in Drug Delivery and Its Commercial Potential.
    Choudhari M; Damle S; Saha RN; Dubey SK; Singhvi G
    AAPS PharmSciTech; 2023 Sep; 24(7):188. PubMed ID: 37715004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement.
    Ueda K; Higashi K; Yamamoto K; Moribe K
    Int J Pharm; 2014 Apr; 464(1-2):205-13. PubMed ID: 24440403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.